145 related articles for article (PubMed ID: 38419066)
21. TRAF1 Coordinates Polyubiquitin Signaling to Enhance Epstein-Barr Virus LMP1-Mediated Growth and Survival Pathway Activation.
Greenfeld H; Takasaki K; Walsh MJ; Ersing I; Bernhardt K; Ma Y; Fu B; Ashbaugh CW; Cabo J; Mollo SB; Zhou H; Li S; Gewurz BE
PLoS Pathog; 2015 May; 11(5):e1004890. PubMed ID: 25996949
[TBL] [Abstract][Full Text] [Related]
22. IGFBP2 upregulates ZEB1 expression and promotes hepatocellular carcinoma progression through NF-κB signaling pathway.
Guo Q; Yu DY; Yang ZF; Liu DY; Cao HQ; Liao XW
Dig Liver Dis; 2020 May; 52(5):573-581. PubMed ID: 31818638
[TBL] [Abstract][Full Text] [Related]
23. ERCC6L promotes the progression of hepatocellular carcinoma through activating PI3K/AKT and NF-κB signaling pathway.
Chen H; Wang H; Yu X; Zhou S; Zhang Y; Wang Z; Huang S; Wang Z
BMC Cancer; 2020 Sep; 20(1):853. PubMed ID: 32891122
[TBL] [Abstract][Full Text] [Related]
24. p55PIK regulates alpha-fetoprotein expression through the NF-κB signaling pathway.
Ye G; Sun G; Cheng Z; Zhang L; Hu K; Xia X; Zhou Y
Life Sci; 2017 Dec; 191():104-110. PubMed ID: 28970114
[TBL] [Abstract][Full Text] [Related]
25. Competition between TRAF2 and TRAF6 regulates NF-kappaB activation in human B lymphocytes.
Zhang W; Zhang X; Wu XL; He LS; Zeng XF; Crammer AC; Lipsky PE
Chin Med Sci J; 2010 Mar; 25(1):1-12. PubMed ID: 20449947
[TBL] [Abstract][Full Text] [Related]
26. E3 ligase RNF167 and deubiquitinase STAMBPL1 modulate mTOR and cancer progression.
Wang D; Xu C; Yang W; Chen J; Ou Y; Guan Y; Guan J; Liu Y
Mol Cell; 2022 Feb; 82(4):770-784.e9. PubMed ID: 35114100
[TBL] [Abstract][Full Text] [Related]
27. Protein-Binding Function of RNA-Dependent Protein Kinase Promotes Proliferation through TRAF2/RIP1/NF-κB/c-Myc Pathway in Pancreatic β cells.
Gao L; Tang W; Ding Z; Wang D; Qi X; Wu H; Guo J
Mol Med; 2015 Feb; 21(1):154-66. PubMed ID: 25715336
[TBL] [Abstract][Full Text] [Related]
28. The PP4R1 subunit of protein phosphatase PP4 targets TRAF2 and TRAF6 to mediate inhibition of NF-κB activation.
Hadweh P; Habelhah H; Kieff E; Mosialos G; Hatzivassiliou E
Cell Signal; 2014 Dec; 26(12):2730-7. PubMed ID: 25134449
[TBL] [Abstract][Full Text] [Related]
29. High expression of tumor necrosis factor receptor-associated factor 2 promotes tumor metastasis and is associated with unfavorable prognosis in gastric cancer.
Zhao J; Li H; Min L; Han X; Shu P; Yang Y; Gan Q; Wang X; Wang H; Ruan Y; Qin J; Sun Y; Qin X
J Gastroenterol Hepatol; 2018 Feb; 33(2):431-442. PubMed ID: 28482378
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of Cell Proliferation and Metastasis by Scutellarein Regulating PI3K/Akt/NF-κB Signaling through PTEN Activation in Hepatocellular Carcinoma.
Ha SE; Kim SM; Vetrivel P; Kim HH; Bhosale PB; Heo JD; Lee HJ; Kim GS
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445559
[TBL] [Abstract][Full Text] [Related]
31. Ubiquitin-specific protease 2a promotes hepatocellular carcinoma progression via deubiquitination and stabilization of RAB1A.
Xiong B; Huang J; Liu Y; Zou M; Zhao Z; Gong J; Wu X; Qiu C
Cell Oncol (Dordr); 2021 Apr; 44(2):329-343. PubMed ID: 33074477
[TBL] [Abstract][Full Text] [Related]
32. STAMBPL1 promotes breast cancer cell resistance to cisplatin partially by stabilizing MKP-1 expression.
Liu R; Yang G; Bao M; Zhou Z; Mao X; Liu W; Jiang X; Zhu D; Ren X; Huang J; Chen C
Oncogene; 2022 Apr; 41(16):2265-2274. PubMed ID: 35236965
[TBL] [Abstract][Full Text] [Related]
33. SHARPIN negatively associates with TRAF2-mediated NFκB activation.
Liang Y
PLoS One; 2011; 6(7):e21696. PubMed ID: 21829440
[TBL] [Abstract][Full Text] [Related]
34. Interaction of the TNFR-receptor associated factor TRAF1 with I-kappa B kinase-2 and TRAF2 indicates a regulatory function for NF-kappa B signaling.
Sughra K; Birbach A; de Martin R; Schmid JA
PLoS One; 2010 Sep; 5(9):e12683. PubMed ID: 20856938
[TBL] [Abstract][Full Text] [Related]
35. Nuclear Met promotes hepatocellular carcinoma tumorigenesis and metastasis by upregulation of TAK1 and activation of NF-κB pathway.
Tey SK; Tse EYT; Mao X; Ko FCF; Wong AST; Lo RC; Ng IO; Yam JWP
Cancer Lett; 2017 Dec; 411():150-161. PubMed ID: 28989054
[TBL] [Abstract][Full Text] [Related]
36. Effects of CircRNA-ITCH on proliferation and apoptosis of hepatocellular carcinoma cells through inhibiting Wnt/β-catenin signaling pathway.
Yang B; Zhao J; Huo T; Zhang M; Wu X
J BUON; 2020; 25(3):1368-1374. PubMed ID: 32862578
[TBL] [Abstract][Full Text] [Related]
37. microRNA-206 prevents hepatocellular carcinoma growth and metastasis via down-regulating CREB5 and inhibiting the PI3K/AKT signaling pathway.
Chi Y; Gong Z; Xin H; Wang Z; Liu Z
Cell Cycle; 2022 Dec; 21(24):2651-2663. PubMed ID: 36003063
[TBL] [Abstract][Full Text] [Related]
38. A dual role for the API2 moiety in API2-MALT1-dependent NF-kappaB activation: heterotypic oligomerization and TRAF2 recruitment.
Lucas PC; Kuffa P; Gu S; Kohrt D; Kim DS; Siu K; Jin X; Swenson J; McAllister-Lucas LM
Oncogene; 2007 Aug; 26(38):5643-54. PubMed ID: 17334391
[TBL] [Abstract][Full Text] [Related]
39. HOXA1 binds RBCK1/HOIL-1 and TRAF2 and modulates the TNF/NF-κB pathway in a transcription-independent manner.
Taminiau A; Draime A; Tys J; Lambert B; Vandeputte J; Nguyen N; Renard P; Geerts D; Rezsöhazy R
Nucleic Acids Res; 2016 Sep; 44(15):7331-49. PubMed ID: 27382069
[TBL] [Abstract][Full Text] [Related]
40. Long noncoding RNA PICSAR/miR-588/EIF6 axis regulates tumorigenesis of hepatocellular carcinoma by activating PI3K/AKT/mTOR signaling pathway.
Liu Z; Mo H; Sun L; Wang L; Chen T; Yao B; Liu R; Niu Y; Tu K; Xu Q; Yang N
Cancer Sci; 2020 Nov; 111(11):4118-4128. PubMed ID: 32860321
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]